Goldwater Institute

10 questions on FDA suits targeting stem cell clinics

SVF2

The FDA via the DOJ has sued to get permanent injunctions against US Stem Cell, Inc. (USRM) and California Stem Cell Treatment Center/Cell Surgical Network (CSN). Both firms use an unapproved fat stem cell product in patients called stromal vascular fraction (the SVF production process is pictured at right) that the FDA indicates is generally …

10 questions on FDA suits targeting stem cell clinics Read More »

Popping the bubble of stem cell populism

pop-bubble-populism

What happens if we mix stem cells with populism? From a populist view of stem cells, everyday patients should be able to do nearly anything they want with stem cells without any governmental interference or excessive expense. Even stem cells not proven to be safe or effective. This can sound like an appealing idea to …

Popping the bubble of stem cell populism Read More »

Upcoming Right-To-Try debate: NYU’s Roxland and Goldwater’s Sandefur

Right-To-Try-Debate-Roxland-Sandefur

Should patients have the Right To Try experimental therapies that could be unsafe and ineffective? What if those patients have a terminal illness and no reasonable prospects of being helpful to conventional medicine? Doesn’t it make perfect sense to let them try a risky approach if they want to do so? On the other hand, …

Upcoming Right-To-Try debate: NYU’s Roxland and Goldwater’s Sandefur Read More »